ArticleInvestigative ophthalmology & visual science2025
F4H5 Alleviates Increased Outflow Resistance Induced by Emulsified Silicone Oil In Vitro.
Article in Investigative ophthalmology & visual science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: The purpose of this study was to investigate the effect of emulsified silicone oil on trabecular outflow resistance using an in vitro perfusion model of human and porcine anterior segments. F4H5, an approved washout for emulsified silicone oil in the posterior segment, was evaluated as a potential rescue treatment. Methods: Seventeen porcine and 15 human anterior segments were dissected and clamped into an in vitro perfusion model. The intraocular pressure (IOP) was recorded continuously and evaluated before and after the injection of emulsified silicone oil, followed by treatment with F4H5 in the intervention group. Control eyes received injections of balanced salt solution (BSS). Results: In human eyes, the injection of emulsified silicone oil significantly increased IOP from 7.8 ± 1.3 millimeters of mercury (mm Hg) to 15.8 ± 3.5 mm Hg (increase of 8.0 ± 2.3 mm Hg, P = 0.02, mean time to stabilized higher pressure = 8.6 hours). Subsequent treatment with F4H5 reverted the IOP back to near baseline values (10.8 ± 2.2 mm Hg, P = 0.06 compared to baseline, mean time to stabilized lower pressure = 6.9 hours). Porcine eyes demonstrated comparable trends, with a significant IOP increase from 14.5 ± 1.2 mm Hg to 17.7 ± 1.6 mm Hg after silicone oil injection (increase of 3.2 ± 0.9 mm Hg, P = 0.01) and a subsequent significant drop in IOP to 12.4 ± 1.0 mm Hg after the injection of F4H5 (decrease of 5.3 ± 1.1 mm Hg, P < 0.01). Conclusions: Emulsified silicone oil leads to blockage of the outflow pathways and an increased IOP in an in vitro human and porcine anterior segment perfusion model. With F4H5, a clinically relevant reversal of this increased outflow resistance was achieved and should be further evaluated.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.